Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Molybdenum trioxide as a newer diversified economic catalyst for the transformation of nitroarenes to arylamine and 5-substituted-1H-tetrazole

Anand Maurya, Upendra Kumar Patel, Sanjeev Kumar and Alka Agarwal*
Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221005, Uttar Pradesh, India. E-mail: agarwal.dralka@gmail.com

Received 27th July 2024 , Accepted 4th September 2024

First published on 18th September 2024


Abstract

The present work has developed a straightforward, gentle, and effective approach for synthesizing arylamines and 5-substituted-1H-tetrazole derivatives, and among the two tested catalysts, molybdenum trioxide (MoO3) proved to be highly effective. The selective hydrogenation of nitroarenes to arylamines presents a significant challenge due to the complex reaction mechanism and the competitive hydrogenation of other reducible functional groups. It facilitated the transfer hydrogenation of nitrobenzene using hydrazine hydrate-produced amino compounds and enabled the [3 + 2] cycloaddition of sodium azide with aromatic nitriles to yield 5-substituted-1H-tetrazoles. The structure of compound 5-(4-bromophenyl)-1H-tetrazole (5k) was verified through single-crystal X-ray analysis, and the calculation of Green Chemistry Metrics showed the optimal range. Notably, the MoO3 catalyst can be reutilized for up to seven cycles with minimal loss of effectiveness. These attributes make molybdenum trioxide particularly attractive for industrial applications. This methodology offers several advantages over traditional synthetic methods.


1 Introduction

Catalysis is integral to numerous chemical processes, serving as the foundation for countless synthetic transformations in research and industrial contexts. Numerous catalytic reagents can significantly enhance the reaction yield and selectivity while allowing for more easily controlled reaction conditions.1 Significant advancements have been made in heterogeneous and homogeneous catalysis over the twentieth century. Heterogeneous catalysis offers the advantage of easy catalyst separation at the end of the reaction, while homogeneous catalysis is known for achieving higher catalytic activity.2 Transition metal oxides have been extensively explored for their applications in various environmental, industrial, and technological fields. Transition metal catalysts were first demonstrated by Busch in 1929, who used Pd/CaCO3,3 and later Pietra,4 who used Pd/C for the hydrazine-facilitated transfer hydrogenation (TH) of nitro-aromatics. Catalytic transfer hydrogenation (CTH) presents an appealing alternative for converting nitroarenes to anilines. It involves the addition of hydrogen from a hydrogen donor compound such as hydrazine,5 formic acid,6 isopropanol,7 or sodium borohydride (NaBH4),8 to an organic molecule, and has recently become a significant research focus.9

A recent study has investigated molybdenum oxide-based catalysts for this reaction.10,11 Studies have suggested that reactive hydrogen species, in the forms of Hδ and Hδ+, are active in reducing nitrobenzene when using MoOx catalysts.10 These hydrogen species are believed to form through hydrazine (N2H4) activation, particularly at low oxidation state molybdenum sites, such as Mo4+ and Mo3+, which serve as adsorption sites.10,11

Molybdenum oxides (MoOx) have demonstrated potential as catalysts due to their various oxidation states, including Mo4+, Mo5+, and Mo6+. They have been utilized in numerous applications such as CO2 hydrogenation, water splitting,12–14 and the reduction of nitrobenzene to aniline. The most effective active sites for the hydrogenation of nitrobenzene are reported to be the acidic sites associated with the low oxidation states of molybdenum, such as Mo5+, Mo4+, and Mo3+. This aligns with observations that molybdenum trioxide (MoO3) has significantly inferior performance to MoOx10,15 due to the presence of Mo6+. Molybdenum trioxide (MoO3) can exist in various phases, including α-(orthorhombic), β-(monoclinic), and h-(hexagonal) forms while MoO3 primarily consists of less active Mo6+ species; these can be reduced to lower oxidation states, altering the catalyst's structure. The in situ reduction of Mo6+ during catalytic reactions has been reported, namely, dehydroaromatization in methane using Mo-loaded HZSM-5[thin space (1/6-em)]16,17 and MoO3/HMCM-49.18 The reduction of Mo6+ by CH4 leads to the formation of Mo2C, which is proposed to be the active phase for this reaction.19 This process can be observed in the reaction profiles as an induction period.17 Recent studies have demonstrated that Mo6+ can be reduced to Mo5+ or Mo4+ in the presence of hydrazine.20 The formation of Mo4+ is significant as it is proposed to be the active site for decomposing N2H4 into reactive hydrogen species.10 This reduction has been observed during the hydrogenation of nitrobenzene to aniline over [FeMo]Sx using N2H4, forming Mo4+.15

According to literature reports, aromatic amines serve as essential components in synthesizing pharmaceuticals, dyes, pigments, polymers, and agrochemicals.21,22 It is also observed that nearly one-fourth of all pharmaceutical amine-containing drugs, such as procaine and phentermine, are widely used (Fig. 1).23,24


image file: d4ra05443a-f1.tif
Fig. 1 Structures of the marketed drugs contain an amine functional group.

These drugs are clinically used for the treatment of local anesthetics and treat conditions like attention deficit hyperactivity disorder (ADHD) and narcolepsy, and the reduction of p-chloronitrobenzene and 8-nitroquinoline into p-chloroaniline and 8-aminoquinoline, respectively. These compounds serve as essential intermediates in the synthesis of paludrine and primaquine, which are important antimalarial drugs (Fig. 1).25

Several methods suffer from drawbacks in synthesizing anilines from nitrobenzene, including harsh reaction conditions, low yields, high temperatures, long reaction times, and costly reagents. Additionally, the catalysts used can be toxic, less accessible, thermally unstable, and exhibit poor functional group tolerance, often leading to side product formation. The preparation and use of these reagents also demand strict conditions. Therefore, significant room remains for improving and developing new, simple, and efficient reagents to address and mitigate these issues.26,27 Following research into metal oxide catalysts, we found that molybdenum trioxide (MoO3) is exceptionally effective at stabilizing hydride and proton when using hydrazine as a hydrogen source.

Tetrazoles are heterocyclic compounds comprising a five-membered ring of one carbon atom and four nitrogen atoms. These compounds can exist in two tautomeric forms: 1H-tetrazole and 2H-tetrazoles. In solution, the 1H-tetrazole form is more stable and commonly found, while the 2H-tetrazole form is more stable in the gas phase.28 Tetrazoles possess a wide array of physicochemical characteristics such as a high dipole moment, elevated formation enthalpy, robust stability, as well as notable acidity, basicity and exhibit diverse biological properties, including coordination chemistry, materials science, medicinal/biological sciences, and catalysis.28–33

Medications incorporating tetrazole compounds are employed in diverse therapeutic areas, encompassing antibacterial,34 antifungal,35 anticancer,36 antitubercular,37 peptides inhibitor,38 and antimalarial treatments.39 The tetrazole moiety is a constituent in several widely utilized drugs, such as losartan, valsartan, cefazolin, irbesartan, and azosemide (Fig. 2).40


image file: d4ra05443a-f2.tif
Fig. 2 Structure of marketed drugs containing the tetrazole moiety.

Due to their excellent adaptability and broad utility, there has been significant interest in exploring the catalytic synthesis of tetrazole derivatives. Due to their widespread applications, 5-substituted tetrazoles have been a focal point in fundamental research.41,42 Previous research on various catalytic systems has enabled scientists to develop methods containing transition metals with precisely defined sizes, which are known as outstanding catalysts.

Keeping the above facts and applications in mind, we made efforts to explore the catalytic use or property of MoO3 in the synthesis of diversified compounds hydrazine-mediated transfer hydrogenation of nitroarenes to arylamines and synthesis of 5-substituted-1H-tetrazoles. The synthesized arylamines and 5-substituted-1H-tetrazoles were characterized by NMR, IR, and HRMS, and a single-crystal XRD study was done for compound 5-(4-bromophenyl)-1H-tetrazole (5k).

2 Experimental

2.1 Materials and methods

All the reagents and solvents were acquired from E. Merck (India), Avra, CDH, and Sigma-Aldrich and were used directly without additional processing. The reactions were monitored using thin-layer chromatography (TLC) on a pre-coated silica gel 60 F254 mesh. The results were observed using UV light or an iodine chamber. Merck silica gel (230–400 mesh) was employed for column chromatography. The compounds melting points were ascertained using the open capillary method, the results of which were uncorrected. The NMR spectra were collected on a Bruker Ascend 600 MHz spectrophotometer operating at 600 MHz for 1H and 151 MHz for 13C experiments. The chemical shifts are reported on a ppm scale concerning CDCl3 (7.269 ppm) for 1H and (77.00 ppm) for 13C NMR and DMSO-d6 (2.5 ppm), 1H (3.5 ppm) for moisture, and (40.39 ppm) for 13C NMR as an internal standard. The abbreviations are s = singlet, d = doublet, t = triplet, q = quartet, dd = double doublet, and m = multiplet. The chemical shifts were gauged in parts per million (ppm) on the delta (δ) scale with tetramethylsilane (TMS) acting as the internal reference. The mass spectra were recorded on a Sciex X500R QTOF mass spectrometer. FT-IR spectra were recorded in KBr pellets in the 4000–400 cm−1 range at room temperature using a PerkinElmer400 FT-IR spectrometer. The single crystal X-ray analysis further verified the synthesized tetrazole compound 5k. Crystals were formed via the slow evaporation of the solution with methanol in the solution technique. The graphite monochromatized Cu-Kα radiation (λ = 1.54184 Å) was used to measure the X-ray diffraction intensity data at 293 K using the X-ray scan method on a Rigaku XtaLAB Synergy-i Single Crystal X-ray Diffractometer with a CCD detector (HyPix-Bantam).

2.2 General procedure for the synthesis of amine derivatives

The synthesis of amine derivatives was carried out using the literature procedure.43 Nitroarene (1 mmol) and N2H4·H2O (4 equiv.) were dissolved in 3 mL of DMSO in an oven-dried 25 mL round bottom flask. MoO3 (22.75 mg, 25 mol%) was added to the reaction mixture and stirred at 120 °C for 15 min. After the completion of the reaction, as monitored by TLC (mobile phase, ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 50[thin space (1/6-em)]:[thin space (1/6-em)]50), the solution was cooled to room temperature, and the catalyst was removed by centrifugation. The reaction mixture was extracted with ethyl acetate (5 mL × 3). The organic layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The final product was purified by silica gel column chromatography using ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane (25[thin space (1/6-em)]:[thin space (1/6-em)]75) as the eluent, and amine derivatives were obtained with a yield of 85–90%.

2.3 General procedure for the synthesis of 5-substituted-1H-tetrazole derivatives

A methodology from the literature was used to synthesize 5-substituted-1H-tetrazole derivatives.44 Benzonitrile (1 mmol) and sodium azide (1.5 mmol) were dissolved in 3 mL DMSO in a 25 mL round bottom flask. MoO3 (20.92 mg, 15 mol%) was added to the reaction mixture and stirred at 140 °C for 1.5 h. After the completion of the reaction (as monitored by TLC, mobile phase = ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 50[thin space (1/6-em)]:[thin space (1/6-em)]50), the solution was cooled to room temperature. The catalyst was removed by centrifugation. Note that 5 mL of ice water was added, followed by the dropwise addition of 3 N HCl until the reaction mixture became strongly acidic (pH 2). The reaction mixture was extracted with ethyl acetate (6 mL × 3). The organic layer was dehydrated with anhydrous sodium sulfate and evaporated in vacuo. The solid mass of 5-phenyl-1H-tetrazole derivatives was obtained with a yield of 85–91%.

3 Results and discussion

3.1 Optimization for the transfer hydrogenation of nitrobenzene

The catalytic efficiency of the catalyst (MoO3 and MoO2) was assessed in the transfer hydrogenation (TH) of nitroarenes employing N2H4·H2O. At first, the reaction was done using nitrobenzene as a benchmark substrate in the absence of the catalyst and N2H4·H2O (6 equiv.) in methanol at 50 °C for 24 h. The reaction did not proceed (entries 1 and 2, Table 1), as monitored by TLC. Under the next optimized reaction conditions, the catalyst (MoO3 and MoO2) (5 mol%) and N2H4·H2O (6 equiv.) were added in methanol at 50 °C for 24 h and the yield was 11% and 10%, respectively (entries 3 and 4, Table 1). On increasing the amount of the catalyst (MoO3, 10 mol%) and using N2H4·H2O (6 equiv.) in ethanol at 60 °C, a yield of 20% was obtained in 24 h (entry 5, Table 1). Under another optimized reaction condition, the amount of hydrazine hydrate was (4 equiv.) and DMSO was used as a solvent at 120 °C. The obtained yield was 45% in 4 h (entry 6, Table 1). Further, MoO2 (10 mol%) was used as a catalyst with hydrazine hydrate (4 equiv.) and DMSO solvent at 120 °C to get a yield of 35% in 6 h (entry 7, Table 1). On enhancing the amount of catalyst (MoO3, 15 mol%) and hydrazine hydrate used (6 equiv.) in DMF at 120 °C, 50% yield was obtained in 8 h (entry 8, Table 1). On further increasing the catalyst amount of both MoO3 and MoO2 using 20 mol%, and hydrazine hydrate (4 and 6 equiv.) in DMSO at 120 °C, the yield obtained was 60% and 42% in 5 h, respectively (entries 9 and 10, Table 1). In DMF solvent, MoO3 was used at 25 mol% with 4 equiv. of hydrazine hydrate at 120 °C, and a yield of 80% was obtained in 2 h (entry 11, Table 1). With the same reaction, conditions were applied in DMSO to get a maximum yield of 90% in 15 min (entry 12, Table 1). Moreover, water was used as a solvent with an appropriate reaction condition at 80 °C but no changes were obtained (entry 13, Table 1). MoO2 was used as 25 mol% in DMSO solvent at 120 °C to get a yield of 48% in 4 h (entry 14, Table 1). Thus, the maximum yield (90%) was observed in DMSO (3 mL) at 120 °C for 15 min (entry 12, Table 1). The scope for the TH of various nitroarenes was investigated (Table 2). Utilizing the optimized conditions, several para- and meta-substituted nitroarenes presented a good-to-excellent yield of nitroamines (85–90%). In the formation of compounds 2d, 2e, and 2h, the selective reduction of the nitro group occurred due to its stronger negative inductive effect compared to that of the CHO/COOH group present in the same substrate moiety.
Table 1 Optimization for the transfer hydrogenation of nitrobenzenea
S. no. Catalyst amount (mol%) N2H4·H2O (equiv.) Solvent Time Temp. (oC) Yieldb (%)
a Reaction condition: nitrobenzene (1 mmol), N2H4·H2O (4 equiv.), solvent (3 mL), and catalyst (mol%).b Isolated yields.
1 Nil, MoO3 6 MeOH 24 h 50
2 Nil, MoO2 6 MeOH 24 h 50
3 5, MoO3 6 MeOH 24 h 50 11
4 5, MoO2 6 MeOH 24 h 50 10
5 10, MoO3 6 EtOH 24 h 60 20
6 10, MoO3 4 DMSO 4 h 120 45
7 10, MoO2 4 DMSO 6 h 120 35
8 15, MoO3 6 DMF 8 h 120 50
9 20, MoO3 4 DMSO 5 h 120 60
10 20, MoO2 6 DMSO 5 h 120 42
11 25, MoO3 4 DMF 2 h 120 80
12 25, MoO3 4 DMSO 15 min 120 90
13 25, MoO3 4 H2O 24 h 80
14 25, MoO2 4 DMSO 4 h 120 48


Table 2 Substrate scope for the MoO3-catalyzed synthesis of amine derivativesa,c
a Reaction condition: nitroarene (1 mmol), MoO3 (25 mol%), hydrazine hydrate (4 mmol), DMSO (3 mL), 120 °C, 15 min.b Isolated yield.c Products were characterized using 1H and 13C spectroscopy and HRMS.
image file: d4ra05443a-u1.tif


Analogues of 2,4-dinitrophenol and picric acid exhibited pseudo-first-order kinetics, as illustrated in Fig. 3(a–d). Upon comparison, it was observed that the rate constant for 2,4-dinitrophenol was higher than that of 2,4,6-trinitrophenol. This variation in the rate constants is attributed to the structural differences between the compounds, with steric hindrance playing a significant role in the di- and tri-substituted derivatives.


image file: d4ra05443a-f3.tif
Fig. 3 (a) UV-vis spectra for the hydrogenation of 2,4-dinitrophenol and (b) relationship between ln(at/a0) and reaction time (min). (c) UV-vis spectra of the hydrogenation of picric acid and (d) relationship between ln(at/a0) and reaction time (min).

In Fig. 4, the plausible mechanism representing the role of MoO3 for synthesizing amine derivatives is shown using nitrobenzene as the representative substrate. The catalytic reduction of nitroarenes to anilines occurs by the reaction of MoO3 with hydrazine hydrate. It forms a complex in situ that reacts with nitroarene to produce the nitroso derivative and diimide intermediate of MoO3. Both the above reacted and formed the hydroxylamine species and nitrogen complex of MoO3 and then underwent reduction with hydrazine hydrate to form the final product, i.e., amine derivative.


image file: d4ra05443a-f4.tif
Fig. 4 Plausible mechanism for the synthesis of amine derivatives using MoO3.

3.2 Optimization of the reaction conditions for the synthesis of 5-phenyl-1H-tetrazole

Our goal is to develop an improved catalytic system by evaluating molybdenum dioxide (MoO2) and molybdenum trioxide (MoO3) for their effectiveness in catalyzing the [3 + 2] cycloaddition between benzonitrile and sodium azide to synthesize 5-phenyl-1H-tetrazole in dimethylsulfoxide (DMSO). We optimized the catalyst amount, solvent, and temperature to achieve a high yield of 5-phenyl-1H-tetrazole in a shorter reaction time. The outcomes of these experiments are summarized in Table 3. In an initial attempt, the reaction was carried out without any catalyst using DMF and DMSO as solvents. However, no progress was observed after 24 h at 140 °C and 120 °C, respectively (entries 1 and 2, Table 3). Thin-layer chromatography (TLC) was used to monitor the progress of the reaction. The effectiveness of MoO2 and MoO3 (2.5 mol%) as catalysts was tested in various solvents (DMSO and DMF) at 140 °C. This resulted in a meagre yield (25–30%) of the desired product after 15 and 12 h, respectively (entries 3 and 4, Table 3). Further, the amount of the catalyst was increased (MoO3 and MoO2) and was taken at 5 mol% in DMSO solvent at 140 °C to get the product; the yield was (40–45%) after 10 and 7 h of the reaction, respectively (entries 5 and 6, Table 3). Again, the reaction was attempted with an increased amount of catalyst (MoO3, 10 mol%) in various solvents (ethanol, acetonitrile, water, DMF, and DMSO) at different temperatures (78 °C, 80 °C, 90 °C, and 140 °C, respectively) (entries 7–11, Table 3). Among these conditions, the highest yield of 5-phenyl-1H-tetrazole (65%) was obtained when DMSO was used as the solvent at 140 °C for 5 h (entry 11, Table 3). Further, in the optimization process, MoO2 (10 mol%) was used as a catalyst in DMSO solvent and a yield of 57% was obtained in 7 h at 140 °C (entry 12, Table 3). In the next step, a larger amount of the catalyst was added to the reaction (MoO3, 15 mol%) in DMF and DMSO solvent system at 140 °C, and the desired yield of the product obtained was 72% in 3 h and 91% in 1.5 h (entries 13 and 14, Table 3). Further, MoO2 (15 mol%) was used in DMF and DMSO solvents and yields of 42% and 45% in 5 h at 140 °C (entries 15–16, Table 3). Thus, the optimized reaction condition was determined to be MoO3 (15 mol%) as a catalyst in DMSO (3 mL) at 140 °C. Under this condition, the product 5-phenyl-1H-tetrazole was isolated with 91% yield after 1.5 h of reaction.
Table 3 Optimization of the reaction conditions for the synthesis of 5-phenyl-1H-tetrazolea
S. no. Catalyst Catalyst amount (mol%) Solvent Temp. (oC) Time (h) Yieldb (%)
a Reaction condition: benzonitrile (1 mmol), NaN3 (1.5 mmol), solvent (3 mL), and catalyst (15 mol%) at 140 °C, 1.5 h.b Isolated yield.
1 MoO3 Nil DMF 140 24
2 MoO2 Nil DMSO 120 24
3 MoO2 2.5 DMSO 140 15 30
4 MoO3 2.5 DMF 140 12 25
5 MoO2 5 DMSO 120 10 40
6 MoO3 5 DMSO 120 7 45
7 MoO3 10 EtOH 78 24
8 MoO3 10 CH3CN 80 12 20
9 MoO3 10 H2O 90 12
10 MoO3 10 DMF 140 6 52
11 MoO3 10 DMSO 140 5 65
12 MoO2 10 DMSO 140 7 57
13 MoO3 15 DMF 140 3 72
14 MoO3 15 DMSO 140 1.5 91
15 MoO2 15 DMF 140 5 42
16 MoO2 15 DMSO 140 5 45


After establishing the optimal reaction conditions, we extended the substrate scope for synthesizing MoO3-catalyzed 5-substituted-1H-tetrazole derivatives to include aromatic and heteroaromatic nitriles. The results, summarized in Table 4, show good to excellent yields (85–91%) of 5-substituted-1H-tetrazoles. Aromatic nitriles with electron-withdrawing groups yielded higher amounts of the corresponding 5-substituted-1H-tetrazoles than those with electron-donating groups. Additionally, heteroaromatic nitriles produced the corresponding 5-substituted-1H-tetrazoles with excellent yields (entry 5n, Table 4).

Table 4 Substrate scope for the MoO3-catalyzed synthesis of 5-substituted-1H-tetrazolesa,c
a Reaction condition: nitrile (1 mmol), NaN3 (1.5 mmol), DMSO (3 mL) and MoO3 (15 mol%) at 140 °C, 1.5 h.b Isolated yields.c Products were characterized using 1H and 13C NMR, IR spectroscopy and HRMS.
image file: d4ra05443a-u2.tif


Fig. 5 illustrates a plausible mechanism for the role of MoO3 in synthesizing 5-substituted-1H-tetrazoles using benzonitrile as a representative substrate. Initially, the nitrogen atom of the azide compound coordinates with MoO3 to form an intermediate. This intermediate facilitates the [3 + 2] cycloaddition between the azide ion and the nitrile compound's (–C[triple bond, length as m-dash]N) bond, resulting in complex formation. After the reaction, MoO3 is separated by centrifugation, and the solution's pH is adjusted to 2 using 3 N HCl to obtain 5-phenyl-1H-tetrazole as the final product. The synthesis approach for 5-substituted-1H-tetrazoles was further validated using single-crystal X-ray analysis of compound 5k. X-ray quality crystals were grown in methanol using the slow evaporation method. Fig. 6 shows the ORTEP diagram of compound 5k, with additional single-crystal X-ray crystallographic details provided in Table 5.


image file: d4ra05443a-f5.tif
Fig. 5 Plausible mechanism for the synthesis of 5-substituted-1H-tetrazoles using MoO3.

image file: d4ra05443a-f6.tif
Fig. 6 ORTEP diagram of compound 5k.
Table 5 Crystal data, data collection, and structure refinement details for compound 5k
CCDC 2288459
Empirical formula C7H5BrN4
Formula weight 112.53
Temperature/K 135.15
Wavelength 1.54184 Å
Crystal system Orthorhombic
Space group Pbcm
Hall group P2c2b
Unit cell dimensions a = 4.14920(10) Å, α = 90°
b = 19.9564(5) Å, β = 90°
c = 9.7232(3) Å, γ = 90°
Volume 805.11(4)
Z 8
Density 1.857
Absorption coefficient 6.521 mm−1
F (000) 440.0
Theta range for data collection 8.862 to 144.142
Index ranges −3 ≤ h ≤ 5
−24 ≤ k ≤ 24
−10 ≤ l ≤ 12
Reflections collected 4708
Absorption correction Multi-scan
Refinement method Full-matrix least-squares on F2
Goodness-of-fit on F2 1.088
Final R indices [I > 2sigma(I)] R1 = 0.0393, wR2 = 0.1207


3.3 Green chemistry parameters

A thorough evaluation of green chemistry metrics was done to assess the synthesis of 5-phenyl-1H-tetrazole (5g). Table S1 presents the comprehensive calculations. Fig. 7 illustrates the outcomes in a radar plot, highlighting key variables pivotal in analyzing the cost-effectiveness of green organic synthesis, ideally under optimal conditions. The radar chart visually elucidates the synergistic correlation among parameters such as reaction mass efficiency, carbon efficiency, atom economy, and the E-factor, signifying the environment-friendly nature of this approach.
image file: d4ra05443a-f7.tif
Fig. 7 Illustrates the outcomes in a radar plot.

3.4 Reusability of the catalyst

The capability of a heterogeneous catalyst that demonstrates convenient recoverability and efficient reusability is crucial for its practical application in industry. In this present investigation, the recoverability and reusability of MoO3 were scrutinized for the synthesis of amine and 5-phenyl-1H-tetrazole derivatives under the optimized reaction conditions. Following the completion of each cycle, MoO3 could be effortlessly retrieved via centrifugation, washed with ethyl alcohol, and subsequently dried at 60 °C in an oven for 1 h, ready for reuse in the subsequent cycle. Remarkably, MoO3 retained its catalytic activity over seven consecutive cycles without any significant decline. The yields (%) obtained for the seven catalytic cycles for both reactions are depicted in Fig. 8(a and b). Furthermore, the purity of the products was confirmed by analyzing the 1H NMR spectra of 4-chloroaniline (2f) and 5-phenyl-1H-tetrazole (5g) synthesized using the recovered catalyst after the seventh cycle.
image file: d4ra05443a-f8.tif
Fig. 8 Plot representing the reusability of MoO3 for the synthesis of (a) 4-chloroaniline (2f) and (b) 5-phenyl-1H-tetrazole (5g) over seven catalytic cycles.

3.5 Previously reported catalyst for the transformation of nitroarenes to arylamine

Based on existing literature, various methodologies have been employed for the transformation of nitroarenes to arylamines (Table 6).
Table 6 Previously reported catalysts for the transformation of nitroarenes to arylaminea
S. no. Catalyst system Catalyst amount Reaction condition Limitations Yield (%) Ref.
a PW = present work.
1 MoO3 25 mol% DMSO (3 mL), 120 °C, 15 min Less reaction time, medium catalyst loading, high yield 90 PW
2 Iron oxide hydroxide 0.2 g Propan-2-ol, refluxed, 39 min More reaction time, more catalyst 99 45
3 Fe-500-1 h 0.025 mmol Alcohol (5 mL), 0.75–12 h, refluxed More reaction time 96.7–100 46
4 Iron(III) oxide hydroxide 0.15 g MeOH (25 mL), 333 K, 1.5 h More reaction time, more catalyst 96–100 47
5 [Co] 19 mol% MeOH (0.3 mL), 50 °C, 6 h More reaction time, low yield 50–60 43
6 MoO2 20 mg EtOH (2 mL), 30–50 °C, 0.5–1 h More reaction time 90–99 48


3.6 Previously reported catalyst for the synthesis of 5-substituted-1H-tetrazole

Based on existing literature, various synthetic methodologies have been employed for the synthesis of 5-substituted-1H-tetrazoles (Table 7).
Table 7 Previously reported catalyst for the synthesis of 5-substituted-1H-tetrazolea
S. no. Catalyst system Catalyst amount Reaction condition Limitations Yield (%) Ref.
a PW = present work.
1 MoO3 15 mol% DMSO (3 mL), 140 °C, 1.5 h Less reaction time, medium catalyst loading, high yield 91 PW
2 PbCl2 10 mg DMF, 120 °C, 8–14 h More reaction time, low yield 81 44
3 CuO-NrGO 10 mg DMF (3 mL), 140 °C, 4 h More reaction time 91 49
4 Cu(OAc)2 25 mol% DMF, 120 °C, 12 h More catalyst, more reaction time 98 50
5 CuFe2O4 40 mol% DMF, 120 °C, 12 h More catalyst, more reaction time, low yield 82 51
6 Fecl3-SiO2 50 mg DMF, 120 °C, 12 h More catalyst, more reaction time, low yield 79 52
7 Mesoporous-Zns 1.0 mmol DMF, 120 °C, 36 h More catalyst, more reaction time, low yield 86 53
8 Graphene 0.03 g DMF (5 mL), 120 o°C, 36 h More catalyst, more reaction time, low yield 63 54
9 SiO2–H2SO4 500 mg DMF (10 mL), refluxed, 5 h More catalyst, more reaction time, low yield 88 55
10 AgNO3 10 mmol DMF (5 mL), 120 °C, 5 h Low yield 83 56
11 GO/ZnO 0.03 g DMF (5 mL), 120 °C, 30 h More catalyst, more reaction time, low yield 78 57


4 Conclusion

In this study, molybdenum dioxide (MoO2) and molybdenum trioxide (MoO3) were utilized as catalysts for two reactions: the transfer hydrogenation of nitrobenzene to arylamine derivatives in DMSO at 120 °C for 15 min and the [3 + 2] cycloaddition between benzonitrile and sodium azide in dimethyl sulfoxide (DMSO) at 140 °C for 1.5 h. MoO3 emerged as the superior catalyst, delivering higher yields and shorter reaction times for the synthesis of the target compounds. The green chemistry metrics for these reactions revealed an E-factor of 0.36 (the ideal value is 0). The identity and purity of the synthesized compounds were verified using various analytical techniques, including 1H and 13C NMR, HRMS, FT-IR, and single-crystal XRD. The key advantages of this methodology include reduced reaction times, a wide range of applicable substrates, milder reaction conditions, and the use of cost-effective catalysts, making it highly appealing for industrial applications.

Data availability

All relevant data are within the manuscript and its additional files. The data are available from the corresponding author on reasonable request.

Author contributions

Anand Maurya: conceptualization; methodology; formal analysis; investigation; writing – original draft; and editing. Upendra Kumar Patel: formal analysis; single-crystal validation. Sanjeev Kumar: formal analysis. Alka Agarwal: conceptualization; resources; supervision; funding acquisition; and editing.

Conflicts of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

A. M. is grateful to the Indian Council of Medical Research (ICMR), New Delhi, India, for the Senior Research Fellowship, wide letter no. 45/33/2022-BIO/BMS, U. K. P. is thankful to the Council of Scientific & Industrial Research (CSIR) HRDG New Delhi, India (Grant no. 09/013(0933)/2020-EMR-I) for the Junior Research Fellowship and Senior Research Fellowship, S. K. is grateful to the Council of Scientific and Industrial Research (CSIR), New Delhi, for the Junior Research Fellowship, file no. 09/0013(15307)/2022-EMR-I and A. A. thank Banaras Hindu University and the Institute of Eminence (IoE no. Dev scheme no. 6031) for financial support. The authors are also thankful to CDC-Banaras Hindu University, India, for providing instrumentation facilities.

References

  1. C. M. Starks and M. Halper, Phase Transfer Catalysis, Springer, Dordrecht, 2012 Search PubMed.
  2. V. Ponec and G. C. Bond, Catalysis by Metal and Alloys, Elsevier, Amsterdam, 1995 Search PubMed.
  3. M. Busch and K. Schulz, Ber. Dtsch. Chem. Ges., 1929, 62, 1458–1466 CrossRef.
  4. Q. Shi, R. Lu, L. Lu, X. Fu and D. Zhaoa, Adv. Synth. Catal., 2007, 349(11–12), 1877–1881 CrossRef CAS.
  5. P. L. Gkizis, M. Stratakis and I. N. Lykakis, Catal. Commun., 2013, 36, 48–51 CrossRef CAS.
  6. R. V. Jagadeesh, D. Banerjee, P. B. Arockiam, H. Junge, K. Junge, M. M. Pohl, J. Radnik, A. Brückner and M. Beller, Green Chem., 2015, 17(2), 898–902 RSC.
  7. M. B. Gawande, H. Guo, A. K. Rathi, P. S. Branco, Y. Chen, R. S. Varma and D. L. Peng, RSC Adv., 2013, 3(4), 1050–1054 RSC.
  8. D. R. Petkar, B. S. Kadu and R. C. Chikate, RSC Adv., 2014, 4(16), 8004–8010 RSC.
  9. D. Wang and D. Astruc, Chem. Rev., 2015, 115(13), 6621–6686 CrossRef CAS PubMed.
  10. C. Zhang, J. Lu, M. Li, Y. Wang, Z. Zhang, H. Chen and F. Wang, Green Chem., 2016, 18(8), 2435–2442 RSC.
  11. S. Luo, Y. Long, K. Liang, J. Qin, Y. Qiao, J. Li, G. Yang and J. Ma, Green Chem., 2021, 23(21), 8545–8553 RSC.
  12. A. Phuruangrat, D. J. Ham, S. Thongtem and J. S. Lee, Electrochem. Commun., 2009, 11(9), 1740–1743 CrossRef CAS.
  13. S. Swathi, G. Ravi, R. Yuvakkumar, S. I. Hong, E. S. Babu, D. Velauthapillai and P. Kumar, Ceram. Int., 2020, 46(14), 23218–23222 CrossRef CAS.
  14. A. I. Alharthi, I. U. Din, M. A. Alotaibi, M. A. Bakht and A. Naeem, Sustain. Chem. Pharm., 2022, 27, 100699 CrossRef CAS.
  15. S. Li, Z. Huang, H. Liu, M. Liu, C. Zhang and F. Wang, Dalton Trans., 2022, 51(4), 1553–1560 RSC.
  16. H. Y. Chen, S. Tang, Z. Y. Zhong, J. Lin and K. L. Tan, Surf. Rev. Lett., 2001, 8(06), 627–632 CrossRef CAS.
  17. I. Vollmer, B. Van Der Linden, S. Ould-Chikh, A. Aguilar-Tapia, I. Yarulina, E. Abou-Hamad, Y. G. Sneider, A. I. Olivos Suarez, J. L. Hazemann, F. Kapteijn and J. Gascon, Chem. Sci., 2018, 9(21), 4801–4807 RSC.
  18. J. Hu, Y. Li, S. Wu, X. Wang, C. Xia, X. Zhao and J. Liu, Molecular, 2022, 27(14), 4404 CrossRef CAS PubMed.
  19. P. Tan, J. Catal., 2016, 338, 21–29 CrossRef CAS.
  20. Y. Li, Y. Fan and Y. Chen, Catal. Lett., 2002, 82, 111–116 CrossRef CAS.
  21. T. Kahl, K. W. Schröder, F. R. Lawrence, W. J. Marshall, H. Höke and R. Jäckh, in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH VerlagGmbH& Co. KGaA, 2000 Search PubMed.
  22. J. F. Hartwig, S. Shekhar and F. Barrios-Landeros, Synthesis of anilines, in The chemistry of anilines, John Wiley & Sons Ltd, 2007, pp. 455–536 Search PubMed.
  23. Y. A. Ruetsch, T. Boni and A. Borgeat, Curr. Top. Med. Chem., 2001, 1(3), 175–182 CrossRef CAS PubMed.
  24. K. Upadhyaya, S. Shukla, B. P. Meena and J. Dwivedi, Curr. Org. Synth., 2024, 21(5), 583–594 CrossRef PubMed.
  25. Y. Zhao, B. Pathak and S. K. Singh, Inorg. Chem., 2014, 53(6), 2904–2909 CrossRef PubMed.
  26. S. Joseph, P. Das, B. Srivastava, H. Nizar and M. Prasad, Tetrahedron Lett., 2013, 54(8), 929–931 CrossRef CAS.
  27. M. Nasrollahzadeh, M. Sajjadi, H. Ghafuri, N. S. S. Bidgoli, A. J. Pombeiro and S. Hazra, Coord. Chem. Rev., 2021, 446, 214132 CrossRef CAS.
  28. E. A. Popova, R. E. Trifonov and V. A. Ostrovskii, Russ. Chem. Rev., 2019, 88(6), 644 CrossRef CAS.
  29. S. S. A. D. M. Abadi and M. A. K. Zarchi, New J. Chem., 2017, 41(18), 10397–10406 RSC.
  30. R. J. Herr, Bioorg. Med. Chem., 2002, 10(11), 3379–3393 CrossRef CAS PubMed.
  31. X. M. Kang, M. H. Tang, G. L. Yang and B. Zhao, Coord. Chem. Rev., 2020, 422, 213424 CrossRef CAS.
  32. M. Y. Wani, M. R. Silva, B. Krishnakumar, S. Kumar, A. S. Al-Bogami, F. M. Aqlan and A. J. F. N. Sobral, J. Heterocycl. Chem., 2019, 56(5), 1613–1621 CrossRef CAS.
  33. M. Nasrollahzadeh, Z. Nezafat, N. S. S. Bidgoli and N. Shafiei, Mol. Catal., 2021, 513, 111788 CrossRef CAS.
  34. F. Gao, J. Xiao and G. Huang, Eur. J. Med. Chem., 2019, 184, 111744 CrossRef CAS PubMed.
  35. M. Anand and A. Alka, Mini-Rev. Med. Chem., 2024, 24, 176–195 CrossRef PubMed.
  36. M. Arshad, A. R. Bhat, S. Pokharel, J.-E. Kim, E. J. Lee, F. Athar and I. Choi, Eur. J. Med. Chem., 2014, 71, 229–236 CrossRef CAS PubMed.
  37. N. Dhiman, K. Kaur and V. Jaitak, Bioorg. Med. Chem., 2020, 28(15), 115599 CrossRef CAS PubMed.
  38. E. A. Popova, R. E. Trifonov and V. A. Ostrovskii, Russ. Chem. Rev., 2019, 88(6), 644 CrossRef CAS.
  39. J. Zhang, S. Wang, Y. Ba and Z. Xu, Eur. J. Med. Chem., 2019, 178, 341–351 CrossRef CAS PubMed.
  40. L. S. Feng, M. J. Zheng, F. Zhao and D. Liu, Arch. Pharmazie, 2021, 354(1), 2000163 CrossRef CAS PubMed.
  41. S. S. A. D. M. Abadi and M. A. K. Zarchi, New J. Chem., 2017, 41(18), 10397–10406 RSC.
  42. R. Mittal and S. K. Awasthi, Synthesis, 2019, 51(20), 3765–3783 CrossRef CAS.
  43. S. Dey, D. Panja, A. Sau, S. D. Thakur and S. Kundu, J. Org. Chem., 2023, 88(14), 10048–10057 CrossRef CAS PubMed.
  44. R. Kant, V. Singh and A. Agarwal, C. R. Chim., 2016, 19(3), 306–313 CrossRef.
  45. Q. Shi, R. Lu, K. Jin, Z. Zhang and D. Zhao, Green Chem., 2006, 8(10), 868–870 RSC.
  46. Y. Li, Yu-X. Zhou, X. Ma and H.-L. Jiang, Chem. Commun., 2016, 52(22), 4199–4202 RSC.
  47. P. S. Kumbhar, J. S. Valente, J. M. M. Millet and F. Figueras, J. Catal., 2000, 191(2), 467–473 CrossRef CAS.
  48. C. Zhang, J. Lu, M. Li, Y. Wang, Z. Zhang, H. Chena and F. Wang, Green Chem., 2016, 18(8), 2435–2442 RSC.
  49. A. Singh and A. Agarwal, Mol. Catal., 2023, 547, 113377 CrossRef CAS.
  50. U. B. Patil, K. R. Kumthekar and J. M. Nagarkar, Tetrahedron Lett., 2012, 53(29), 3706–3709 CrossRef CAS.
  51. B. Sreedhar, A. Suresh Kumar and D. Yada, Tetrahedron Lett., 2011, 52(28), 3565–3569 CrossRef CAS.
  52. M. N. zadeh, Y. Bayat, D. Habibi and S. Moshaee, Tetrahedron Lett., 2009, 50(31), 4435–4438 CrossRef.
  53. L. Lang, H. Zhou, M. Xue, X. Wang and Z. Xu, Mater. Lett., 2013, 106, 443–446 CrossRef CAS.
  54. G. Qi, W. Zhang and Y. Dai, Res. Chem. Intermed., 2015, 41, 1149–1155 CrossRef CAS.
  55. Z. Du, C. Si, Y. Li, Y. Wang and J. Lu, Int. J. Mol. Sci., 2012, 13(4), 4696–4703 CrossRef CAS PubMed.
  56. P. Mani, A. K. Singh and S. K. Awasthi, Tetrahedron Lett., 2014, 55(11), 1879–1882 CrossRef CAS.
  57. M. Nasrollahzadeh, B. Jaleh and A. Jabbari, RSC Adv., 2014, 4(69), 36713–36720 RSC.

Footnote

Electronic supplementary information (ESI) available. CCDC 2288459. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d4ra05443a

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.